Full Text View
Tabular View
No Study Results Posted
Related Studies
Immunogenicity of GSK Bio's HPV Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age
This study has been completed.
Study NCT00423046   Information provided by GlaxoSmithKline
First Received: January 16, 2007   Last Updated: May 21, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cervical Cancer
Papillomavirus Infection
Additional conditions recognized in this trial
Communicable Diseases
Infection
Papillomavirus Infections
More general conditions related to this trial
DNA Virus Infections
Tumor Virus Infections
Virus Diseases
Interventions listed in this trial
Gardasil ® (Merck & Co. Inc)
Placebo
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services